Source:http://linkedlifedata.com/resource/pubmed/id/16093451
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2005-9-26
|
pubmed:abstractText |
The pivotal role of PDGF-B for mesangioproliferative glomerular disease is well established. Here, Y-box protein-1 (YB-1) was identified as a downstream signaling target of PDGF-B. In healthy kidney cells, YB-1 was located predominantly within the nuclear compartment. Subsequent to PDGF-B infusion and in the course of anti-Thy1.1-induced mesangioproliferative glomerulonephritis, relocalization of YB-1 into the cytoplasm was observed. In experimental models that lack profound mesangial cell proliferation (e.g., Puromycin-nephrosis, passive Heyman nephritis, spontaneous normotensive nephrosclerosis, hyperlipidemic diabetic nephropathy), YB-1 remained nuclear. This translocation coincided with upregulation of YB-1 protein levels within the mesangial compartment. Increased YB-1 expression and subcellular shuttling was dependent on PDGF-B signaling via the mitogen-activated protein kinase pathway because these alterations were prevented by specific PDGF aptamers and the mitogen-activated protein kinase pathway inhibitor U0126. Furthermore, PDGF-B strongly induced YB-1 expression in vitro. This induction was important because RNAi-dependent knockdown of YB-1 abolished the mitogenic PDGF-B effect. Taken together, YB-1 seems to represent a specific and necessary PDGF-B target in mesangioproliferative glomerular disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1046-6673
|
pubmed:author |
pubmed-author:BokemeyerDirkD,
pubmed-author:EitnerFrankF,
pubmed-author:FloegeJuergenJ,
pubmed-author:Lüscher-FirzlaffJuliane MJM,
pubmed-author:LüscherBernhardB,
pubmed-author:MartinkusSandraS,
pubmed-author:MertensPeter RPR,
pubmed-author:OstendorfTammoT,
pubmed-author:ThieltgesSabrina RSR,
pubmed-author:van RoeyenClaudia R CCR
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2985-96
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16093451-Animals,
pubmed-meshheading:16093451-Cell Division,
pubmed-meshheading:16093451-Cells, Cultured,
pubmed-meshheading:16093451-Glomerular Mesangium,
pubmed-meshheading:16093451-Glomerulonephritis, Membranoproliferative,
pubmed-meshheading:16093451-Humans,
pubmed-meshheading:16093451-Male,
pubmed-meshheading:16093451-Mesangial Cells,
pubmed-meshheading:16093451-Protein Transport,
pubmed-meshheading:16093451-Proto-Oncogene Proteins c-sis,
pubmed-meshheading:16093451-RNA, Messenger,
pubmed-meshheading:16093451-Rats,
pubmed-meshheading:16093451-Rats, Wistar,
pubmed-meshheading:16093451-Y-Box-Binding Protein 1
|
pubmed:year |
2005
|
pubmed:articleTitle |
Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease.
|
pubmed:affiliation |
Medical Clinic II, University Hospital Aachen, Pauwelsstrasse 30, 52057 Aachen, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|